News

Fusobacteria use a special sugar-binding protein to bind to colon tumors

Boston, MA — Some bacteria, called fusobacteria, commonly found in the mouth, use a sugar-binding protein to stick to developing colorectal polyps and cancers, according to a new study by researchers from Harvard T.H. Chan School of Public Health and Hebrew University-Hadassah School of Dental Medicine. While certain fusobacteria have previously been shown to worsen colorectal cancer in animals by the ...

Read More »

‘Generic’ Biologic Drugs Appear Comparable to Brand-Name Counterparts

NEW ANALYSIS SUGGESTS COMMON AND COSTLY MEDICATIONS MADE FROM LIVING CELLS CAN BE EQUIVALENT EVEN WHEN MANUFACTURED BY DIFFERENT COMPANY Generic forms of a biologic drug used to treat rheumatoid arthritis, inflammatory bowel disease and psoriasis appear to be as safe and effective as their brand-name counterparts, a new Johns Hopkins Bloomberg School of Public Health analysis suggests. Biologics, or ...

Read More »

Higher weekly activity levels linked to lower risk of five

Daily activity levels need to be several times higher than recommended minimum Higher levels of total physical activity are strongly associated with lower risk of five common chronic diseases – breast and bowel cancer, diabetes, heart disease and stroke, finds a study in The BMJ today. Many studies have shown the health benefits of physical activity. This has led the ...

Read More »

Dekalb Endoscopy Center Acquired by Physicians Endoscopy

BURLINGTON, N.J., Aug. 2, 2016 /PRNewswire/ — The physicians and staff of Burlington County Endoscopy Center (BCEC) are pleased to announce the formation of a new joint venture between BCEC and Virtua. Built in 2008, BCEC started as a partnership between Gastroenterology Consultants of South Jersey and Physicians Endoscopy, their strategic corporate partner. Currently, approximately 8,000 procedures a year are ...

Read More »

EndoChoice Receives FDA Clearance for Lumos™ with Adaptive Matrix Imaging

Image Enhancement Software Shows Promise As Detection Aid During GI Procedures ALPHARETTA, Ga., Aug. 3, 2016 /PRNewswire/ — EndoChoice Holdings, Inc. (NYSE: GI) announced the recent FDA clearance and US launch of Lumos™ with Adaptive Matrix Imaging. This novel and proprietary imaging software system will now be part of the Company’s Generation 3 Fuse® Full Spectrum Endoscopy® System. EndoChoice scientists ...

Read More »